In in vitro susceptibility tests, the new penem 429 
In the past several years, many 1-lactam antibiotics with broad antibacterial activities have undergone clinical trials. The penem antibiotics FCE22101 and SY5555 have broad antimicrobial spectra and high levels of stability to ,B-lactamases (4, 9) . The in vitro activity of CP-65,207 was previously reported by Gootz et al. (3) ; CP-65,207 is a mixture of stereoisomers of the optically pure CP-70,429. CP-70,429 is a new penem antibiotic, which is stable to renal dehydropeptidase I (2, 8) . We report here the in vitro antibacterial activity of CP-70,429 and its stability to various types of P-lactamases. The following antibacterial agents were used: CP-70,429, Pfizer Pharmaceuticals Inc., Tokyo, Japan; FCE22101, Farmitalia Carlo Erba Co., Ltd., Tokyo, Japan; SY5555, Suntory Co., Ltd., Tokyo, Japan; ceftazidime, Nihon Glaxo Co., Ltd., Tokyo, Japan; and cefuzonam, Lederle Japan Co., Ltd., Tokyo, Japan. The clinical isolates of bacteria used in the present study were collected from several hospitals in Japan from 1984 to 1990. The 3-lactamase-producing strains tested were selected from stock cultures in our laboratory (1, 7) . MICs were determined by the twofold agar dilution method by using Sensitivity Disk Agar (Nissui Pharmaceutical, Tokyo, Japan), unless otherwise specified (5) . The final cell inoculum was approximately 104 CFU per spot.
The various types of ,-lactamases used in the present study were totally or partially purified by the methods reported previously and were stored at -80°C (6) . The stability of the antibiotics to P-lactamase was measured by a spectrophotometric assay (10) .
The MICs of CP-70,429 and the other agents for 1,555 clinical isolates are summarized in Table 1 The antibacterial activity of CP-70,429 against 3-lactamase-producing strains of various species was tested. CP-70,429 showed potent activity against the organisms tested except for Pseudomonas aeruginosa and Xanthomonas maltophilia (Table 2 ). In particular, CP-70,429 was 16-to 128-fold more active than the comparison compounds against P-lactamase-producing strains of Enterobacter cloacae and Citrobacterffreundii.
The susceptibility of CP-70,429 to enzymatic hydrolysis was tested with various types of ,B-lactamases. Hydrolysis of the tested compounds was expressed as the relative rate of hydrolysis normalized with respect to the rate of hydrolysis of cephaloridine or penicillin G, which was set at 100 (Table  3) .
CP . 25->400 50->400 0.39-100 6.25->400 (1) is given. b Relative to the hydrolysis rate for cephaloridine (cephalosporinase and oxyiminocephalosporinase) or benzylpenicillin (penicillinase), which was taken as 100.
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